GLUMON Next generation in-blood glucose monitoring using non-invasive optoacoustic sensing
- Coordinator
- Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt GmbH, Germany
- Runs
- 1 May 2022 to 30 April 2026
- Status
- Running
- EU funding
- €2.2m
- Total cost
- €2.3m
- Partners
- 6 organisations in 4 countries
- Type
- European Innovation Council
- Grant agreement
- 101058111
What the project is doing
In the project's own words, from its summary on CORDIS.
GLUMON aims to leverage a new class of a biomedical optoacoustic sensor developed under the FETOpen project RSENSE (GA #862811) and offer the next generation of non-invasive biochemical in-vivo sensing. The preliminary sensor for non-invasive in-blood glucose sensing has already produced outstanding findings and places the technology well ahead of its competition. Addressing the limitations of existing sensors, mainly accurate non-invasive continuous monitoring of blood-glucose as well as comfort, the GLUMON sensor will better address diabetes healthcare needs.
As a secondary goal and contingency plan, GLUMON will exploit this technology as a lipid sensor and build further potential by addressing the emerging precision nutrition market. The objectives of the GLUMON project are to:1) mature the technology from a lab bench-top setup to a functional portable sensor prototype
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt GmbH | Neuherberg | Germany | Coordinator |
| Medizinische Universitat Graz | Graz | Austria | Participant |
| Klinikum Der Technischen Universität München (tum Klinikum) | Muenchen | Germany | Participant |
| Sthesis GmbH | Wessling | Germany | Participant |
| Alira Health SL | Barcelona | Spain | Participant |
| Rayfos Ltd | Basingstoke | United Kingdom | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI